DETERMARX Trademark

Trademark Overview

On Wednesday, November 6, 2019, a trademark application was filed for DETERMARX with the United States Patent and Trademark Office. The USPTO has given the DETERMARX trademark a serial number of 88983793. The federal status of this trademark filing is REGISTERED as of Tuesday, March 22, 2022. This trademark is owned by OncoCyte Corporation. The DETERMARX trademark is filed in the Medical Instrument Products category with the following description:

Biopsy tests and devices, namely, medical instruments for use in performing tissue biopsies and medical diagnostic apparatus for testing biomarkers; cancer screening tests and devices, namely, medical devices for detecting risk factors and probability of cancer reoccurrence; medical testing device for diagnosing cancer and detecting bioloigical traits that effect the risk of reoccurrence; medical testing devices for tumor diagnosis
determarx

General Information

Serial Number88983793
Word MarkDETERMARX
Filing DateWednesday, November 6, 2019
Status700 - REGISTERED
Status DateTuesday, March 22, 2022
Registration Number6680289
Registration DateTuesday, March 22, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 2, 2020

Trademark Statements

Goods and ServicesBiopsy tests and devices, namely, medical instruments for use in performing tissue biopsies and medical diagnostic apparatus for testing biomarkers; cancer screening tests and devices, namely, medical devices for detecting risk factors and probability of cancer reoccurrence; medical testing device for diagnosing cancer and detecting bioloigical traits that effect the risk of reoccurrence; medical testing devices for tumor diagnosis

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, November 14, 2019
Primary Code010
First Use Anywhere DateFriday, January 31, 2020
First Use In Commerce DateFriday, January 31, 2020

Trademark Owner History

Party NameOncocyte Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618
Party NameOncocyte Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrvine, CA 92618
Party NameOncoCyte Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAlameda, CA 94501

Trademark Events

Event DateEvent Description
Tuesday, March 22, 2022REGISTERED-PRINCIPAL REGISTER
Friday, February 18, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, February 17, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, February 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 8, 2022STATEMENT OF USE PROCESSING COMPLETE
Friday, January 28, 2022USE AMENDMENT FILED
Tuesday, February 8, 2022DIVISIONAL PROCESSING COMPLETE
Friday, January 28, 2022DIVISIONAL REQUEST RECEIVED
Tuesday, February 8, 2022EXTENSION 3 GRANTED
Friday, January 28, 2022EXTENSION 3 FILED
Friday, January 28, 2022TEAS REQUEST TO DIVIDE RECEIVED
Friday, January 28, 2022TEAS EXTENSION RECEIVED
Friday, January 28, 2022TEAS STATEMENT OF USE RECEIVED
Thursday, July 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 27, 2021EXTENSION 2 GRANTED
Tuesday, July 27, 2021EXTENSION 2 FILED
Tuesday, July 27, 2021TEAS EXTENSION RECEIVED
Wednesday, March 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 10, 2021CORRECTED NOA E-MAILED
Tuesday, March 9, 2021EXTENSION 1 GRANTED
Thursday, January 28, 2021EXTENSION 1 FILED
Tuesday, March 9, 2021DIVISIONAL PROCESSING COMPLETE
Monday, December 7, 2020DIVISIONAL REQUEST RECEIVED
Tuesday, February 16, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 28, 2021TEAS REQUEST TO DIVIDE RECEIVED
Thursday, January 28, 2021TEAS EXTENSION RECEIVED
Tuesday, July 28, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, June 17, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 17, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 17, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 2, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 2, 2020PUBLISHED FOR OPPOSITION
Wednesday, May 13, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 28, 2020ASSIGNED TO LIE
Tuesday, April 21, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 20, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 20, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 20, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 3, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 3, 2020NON-FINAL ACTION E-MAILED
Monday, February 3, 2020NON-FINAL ACTION WRITTEN
Wednesday, January 29, 2020ASSIGNED TO EXAMINER
Thursday, November 14, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, November 9, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

determarx medical devices testing cancer namely risk reoccurrence tests detecting diagnosing